Cell-based therapy in soft tissue sports injuries of the knee: a systematic review

References

• Andia I, Maffulli N. New biotechnologies for musculoskeletal injuries [Internet]. Surgeon. Elsevier Ltd; 2019 [cited 2020 Jul 4]. p. 244–255. Available from: https://pubmed.ncbi.nlm.nih.gov/30170915/.
   Google Scholar
• National Institutes of Health US. The adult stem cell | stemcells.nih.gov [Internet]. [ cited 2020 Dec 11]. Available from: https://stemcells.nih.gov/info/2001report/chapter4.htm.
   Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315–317.
   PubMed Web of Science ®Google Scholar
• Chu CR, Rodeo S, Bhutani N, et al. Optimizing clinical use of biologics in orthopaedic surgery: consensus recommendations from the 2018 AAOS/NIH U-13 Conference. J Am Acad Orthop Surg. 2019;27:e50–e63.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: the international society for cellular therapy position statement. Cytotherapy. 2005 [cited 2020 Jul 4];7:393–395.
   PubMed Web of Science ®Google Scholar
• Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641–650.
   PubMed Web of Science ®Google Scholar
• Caplan AI. Mesenchymal stem cells: time to change the name. Stem Cells Transl Med. 2017;6:1445–1451.
   PubMed Web of Science ®Google Scholar
• Phinney DG, Sensebé L. Mesenchymal stromal cells: misconceptions and evolving concepts. Cytotherapy. 2013;15:140–145.
   PubMed Web of Science ®Google Scholar
• Tetta C, Consiglio AL, Bruno S, et al. The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair? Muscles. Ligaments Tendons J. CIC Edizioni Internazionali; 2012 [cited 2020 Jul 6]. p. 212–221. Available from: /pmc/articles/PMC3666529/?report=abstract.
   Google Scholar
• Cheng L, Zhang K, Wu S, et al. Focus on mesenchymal stem cell-derived exosomes: opportunities and challenges in cell-free therapy. Stem Cells Int. 2017. Hindawi Limited. 2017 [cited 2020 Dec 11]:1–10.
   Web of Science ®Google Scholar
• Mushahary D, Spittler A, Kasper C, et al. Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytom Part A. 2018;93(1):19–31.
   PubMedGoogle Scholar
• Dehghani B, Rodeo S, Cell therapy—a basic science primer for the sports medicine clinician. Curr Rev Musculoskelet Med. Springer; 2019 [cited 2020 Jul 4];12(4):436–445.
   PubMed Web of Science ®Google Scholar
• Murray IR, Chahla J, Safran MR, et al. International expert consensus on a cell therapy communication tool: DOSES. J Bone Jt Surg Am. 2019;101(10):904–911.
   PubMed Web of Science ®Google Scholar
• Rodeo SA, Cell therapy in orthopaedics: where are we in 2019? Bone Joint J. [cited 2020 Jul 4]. 2019;101-B(4):361–364.
   PubMedGoogle Scholar
• Migliorini F, Tingart M, Maffulli N, Progress with stem cell therapies for tendon tissue regeneration. Expert Opin Biol Ther. 2020 [cited 2020 Jul 7];20(11):1373–1379.
   PubMed Web of Science ®Google Scholar
• Murray IR, Chahla J, Frank RM, et al. Rogue stem cell clinics. Bone Jt J. 2020;102:148–154.
   PubMedGoogle Scholar
• Would YOU pay £8,000 for Princess Pushy’s stem cell arthritis treatment? Daily mail online [internet]. [cited 2020 Jul 4]. Available from: https://www.dailymail.co.uk/health/article-7981637/Would-pay-8-000-Princess-Pushys-stem-cell-arthritis-treatment.html.
   Google Scholar
• Erikainen S, Couturier A, Chan S Science as culture marketing experimental stem cell therapies in the UK: biomedical lifestyle products and the promise of regenerative medicine in the digital era. 2019 [cited 2020 Jul 4]; Available from: https://www.tandfonline.com/action/journalInformation?journalCode=csac20.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;332–336. Available from https://pubmed.ncbi.nlm.nih.gov/19622551/.
   Google Scholar
• JBJS, Inc. Journals level of evidence : JBJS [Internet]. [cited 2020 Jun 9]. Available from: https://journals.lww.com/jbjsjournal/Pages/Journals-Level-of-Evidence.aspx.
   Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 [cited 2020 Jul 4];366. DOI:10.1136/bmj.l4898http://www.bmj.com/
   Web of Science ®Google Scholar
• Viswanathan M, Patnode C, Berkman ND, et al. Assessing the risk of bias in systematic reviews of health care interventions. Methods Guid Comp Eff Rev. 2017. [cited 2020 Jun 11]. DOI:10.23970/AHRQEPCMETHGUIDE2
   Google Scholar
• Wang Y, Shimmin A, Ghosh P, et al. Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial. Arthritis Res Ther. 2017;19(1):180.
   PubMedGoogle Scholar
• Alentorn-Geli E, Seijas R, Martínez-de la Torre A, et al. Effects of autologous adipose-derived regenerative stem cells administered at the time of anterior cruciate ligament reconstruction on knee function and graft healing. J Orthop Surg. 2019;27(3):2309499019867580.
   Web of Science ®Google Scholar
• Centeno CJ, Pitts J, Al-Sayegh H, et al. Anterior cruciate ligament tears treated with percutaneous injection of autologous bone marrow nucleated cells: a case series. J Pain Res. 2015;8:437–447.
   PubMed Web of Science ®Google Scholar
• Centeno C, Markle J, Dodson E, et al. Symptomatic anterior cruciate ligament tears treated with percutaneous injection of autologous bone marrow concentrate and platelet products: a non-controlled registry study. J Transl Med. 2018;16(1):246.
   PubMedGoogle Scholar
• Silva A, Sampaio R, Fernandes R, et al. Is there a role for adult non-cultivated bone marrow stem cells in ACL reconstruction? Knee Surg Sport Traumatol Arthrosc. 2014;22(1):66–71.
   PubMed Web of Science ®Google Scholar
• Pascual-Garrido C, Rolón A, Makino A. Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: a 5-year-followup. Stem Cells Int. 2012;2012:953510.
   PubMed Web of Science ®Google Scholar
• Clarke AW, Alyas F, Morris T, et al. Skin-derived tenocyte-like cells for the treatment of patellar tendinopathy. Am J Sport Med. 2011;39:614–623.
   PubMed Web of Science ®Google Scholar
• Tallon C, Maffulli N, Ewen SWB. Ruptured Achilles tendons are significantly more degenerated than tendinopathic tendons. Med Sci Sports Exerc. 2001 [cited 2020 Jul 31];33:1983–1990. Available from: https://pubmed.ncbi.nlm.nih.gov/11740288/.
   PubMed Web of Science ®Google Scholar
• Akkaya M, Şimşek ME, Gürsoy S, et al. Medial meniscus scaffold implantation in combination with concentrated bone marrow aspirate injection: minimum 3-year follow-up. J Knee Surg. 2020;33:838–845.
   Web of Science ®Google Scholar
• Pak J, Lee JH, Lee SH. Regenerative repair of damaged meniscus with autologous adipose tissue-derived stem cells. Biomed Res Int. 2014;2014:436029.
   PubMed Web of Science ®Google Scholar
• Centeno CJ, Busse D, Kisiday J, et al. Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Med Hypotheses. 2008;71:900–908.
   PubMed Web of Science ®Google Scholar
• Vangsness CT, Farr J, Boyd J, et al. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Jt Surg Am. 2014;96:90–98.
   PubMed Web of Science ®Google Scholar
• Sekiya I, Koga H, Otabe K, et al. Additional use of synovial mesenchymal stem cell transplantation following surgical repair of a complex degenerative tear of the medial meniscus of the knee: a case report. Cell Transplant. 2019;28:1445–1454.
   PubMed Web of Science ®Google Scholar
• Whitehouse MR, Howells NR, Parry MC, et al. Repair of torn avascular meniscal cartilage using undifferentiated autologous mesenchymal stem cells: from in vitro optimization to a first-in-Human Study. Stem Cells Transl Med. 2017;6:1237–1248.
   PubMed Web of Science ®Google Scholar
• Olivos-Meza A, Pérez Jiménez FJ, Granados-Montiel J, et al. First clinical application of polyurethane meniscal scaffolds with mesenchymal stem cells and assessment of cartilage quality with t2 mapping at 12 months. Cartilage. 2019;1947603519852415. Available from https://www.ncbi.nlm.nih.gov/pubmed/31387368
   Google Scholar
• Hirschmann A, Schiapparelli FF, Schenk L, et al. The genovese grading scale is not reliable for MR assessment of collagen meniscus implants. Knee. 2017 [cited 2020 Jul 4];24:9–15.
   PubMed Web of Science ®Google Scholar
• Rubio-Azpeitia E, Andia I. Partnership between platelet-rich plasma and mesenchymal stem cells: in vitro experience. Muscles Ligaments Tendons J. 2014;4:52–62.
   PubMedGoogle Scholar
• Giai Via A, Frizziero A, Oliva F. Biological properties of mesenchymal stem cells from different sources. Muscles Ligaments Tendons J. 2012;2:154–162.
   PubMedGoogle Scholar
• Andia I, Maffulli N, Burgos-Alonso N. Stromal vascular fraction technologies and clinical applications. Expert Opin Biol Ther. 2019;1912:1289–1305.
   PubMed Web of Science ®Google Scholar
• Hernigou P, Poignard A, Beaujean F, et al. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Jt Surg Am. 2005;87:1430–1437. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15995108.
   PubMed Web of Science ®Google Scholar
• Via AG, Mccarthy MB, De Girolamo L, et al. Making them commit: strategies to influence phenotypic differentiation in mesenchymal stem cells. Sports Med Arthrosc. 2018;26:64–69.
   PubMed Web of Science ®Google Scholar
• Neri S. Genetic stability of mesenchymal stromal cells for regenerative medicine applications: a fundamental biosafety aspect. Int J Mol Sci. 2019;20. DOI:10.3390/ijms20102406
   Web of Science ®Google Scholar
• Asopa V, Vincent T, Saklatvala J. The effects of age and cell isolation on collagen II synthesis by articular chondrocytes: evidence for transcriptional and posttranscriptional regulation. Biomed Res Int. 2020 [cited 2020 Jul 6];2020. Available from: https://pubmed.ncbi.nlm.nih.gov/32461985/.
   PubMed Web of Science ®Google Scholar
• Charif N, Li YY, Targa L, et al. Aging of bone marrow mesenchymal stromal/stem cells: implications on autologous regenerative medicine. Biomed Mater Eng. 2017;28:S57–S63.
   PubMed Web of Science ®Google Scholar
• Von Bahr L, Batsis I, Moll G, et al. Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells 2012 [cited 2020 Dec 11];30:1575–1578.
   PubMed Web of Science ®Google Scholar
• Andia I, Martin JI, Maffulli N. Platelet-rich plasma and mesenchymal stem cells: exciting, but … are we there yet? Sports Med Arthrosc. 2018;26:59–63.
   PubMed Web of Science ®Google Scholar
• Silva LHA, Antunes MA, Dos Santos CC, et al. Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases [Internet]. Stem Cell Res Ther. BioMed Central Ltd. 2018 [cited 2020 Dec 12]. p. 45. Available from: https://stemcellres.biomedcentral.com/articles/10.1186/s13287-018-0802-8
   PubMedGoogle Scholar
• Pezzi A, Amorin B, Laureano Á, et al. Effects of hypoxia in long-term in vitro expansion of human bone marrow derived mesenchymal stem cells. J Cell Biochem. 2018 [cited 2020 Dec 12];93(10):3072–3079.
   Google Scholar
• Hu C, Li L. Preconditioning influences mesenchymal stem cell properties in vitro and in vivo. J Cell Mol Med. Blackwell Publishing Inc.; 2018 [cited 2020 Dec 12]:1428–1442. DOI:10.1111/jcmm.13492
   PubMed Web of Science ®Google Scholar
• Brewer JM, McCarthy MB, Pauzenburger L, et al. Evaluation of concentrated bone marrow-derived mesenchymal stem cells produced from two different cellular concentrating systems. Muscles Ligaments Tendons J. 2019;9:463–469.
   Google Scholar
• Robinson PG, Murray IR, West CC, et al. Reporting of mesenchymal stem cell preparation protocols and composition: a systematic review of the clinical orthopaedic literature. Am J Sport Med. 2019;47(4):991–1000.
   PubMed Web of Science ®Google Scholar
• Docking SI, Ooi CC, Connell D. Tendinopathy: is imaging telling us the entire story. J Orthop Sports Phys Ther. 2015;45:842–852.
   PubMed Web of Science ®Google Scholar
• Samuelsen BT, Webster KE, Johnson NR, et al. Hamstring autograft versus patellar tendon autograft for ACL reconstruction: is there a difference in graft failure Rate? A meta-analysis of 47,613 Patients. Clin Orthop Relat Res. 2017;475:2459–2468.
   PubMed Web of Science ®Google Scholar
• Rodas G, Soler R, Balius R, et al. Autologous bone marrow expanded mesenchymal stem cells in patellar tendinopathy: protocol for a phase I/II, single-centre, randomized with active control PRP, double-blinded clinical trial. J Orthop Surg Res. 2019 [cited 2020 Jul 4];14. DOI:10.1186/s13018-019-1477-2
   PubMed Web of Science ®Google Scholar